FDA authorizes updated COVID-19 vaccines for young children

The Food and Drug Administration today authorized the Moderna and Pfizer bivalent COVID-19 vaccines for emergency use in children as young as 6 months old. Specifically, the agency authorized the Moderna vaccine as a single booster dose for children aged 6 months through 5 at least two months after primary vaccination, and the Pfizer vaccine for children aged 6 months through 4 who have not yet received the third primary series dose. Before providers can start administering the bivalent doses, the Centers for Disease Control and Prevention must recommend them for these age groups.
Related News Articles
Headline
The latest video in the AHA’s series “Medicaid: Real Lives, Real Care” features Melissa Fannon-Wisner, DNP, nurse educator and nurse practitioner at Valley…
Headline
Kevin McEwan, DNP, R.N., chief nursing officer at Madison Memorial Hospital, shares how Medicaid provides vital behavioral health and maternal and child care…
Headline
The Alliance for Innovation on Maternal Health, with support from the Health Resources and Services Administration, will host a five-part learning series…
Blog
Even before the COVID pandemic, the mental health and wellness of our young people was failing. The pandemic exacerbated the crisis and made it difficult for…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…